Merck & Co., Inc.
NYSE: MRK
$81.90
-$0.86 (-1.0%)
Closing price September 29, 2020
Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service and WPX Energy.
1 day ago
Last Updated: 1 day ago
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week...
1 month ago
Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66, Starbucks and Vital Farms.
1 month ago
Last Updated: 1 month ago
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be...
1 month ago
Last Updated: 1 month ago
Monday's top analyst upgrades and downgrades included AbbVie, DuPont, Etsy, Expedia, Exxon Mobile, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, Visa and Yum! Brands.
1 month ago
Last Updated: 1 month ago
When Merck & Co. (NYSE: MRK) reported its second-quarter financial results before the markets opened on Wednesday, the pharmaceutical giant said that it had earnings per share (EPS) of $1.37 and...
1 month ago
24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week, including Apple, Boeing, Exxon, McDonald's and Visa.
2 months ago
Merck shares jumped on Tuesday after the company announced that it has made deals to develop drugs in the fight against COVID-19.
4 months ago
Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering, investors were not thrilled about this quarter for these two...
5 months ago
Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.
5 months ago
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
5 months ago
Over one-third of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. Here's what to expect.
5 months ago
The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
5 months ago
24/7 Wall St. wanted to see which companies have the best chance at not having to lower their dividends at all and those that almost certainly will retain much of their current dividends in a...
6 months ago
Last Updated: 6 months ago
The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical stocks decreased.
6 months ago
Last Updated: 6 months ago